RITCHELL VILLALUZ: Open Payments
NPI 1184118101 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 63 payments from 16 companies in 2025. Trend: 2023 $2,065 · 2024 $2,211 · 2025 $1,797
Food & beverage: $1,797
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $251 |
| AstraZeneca Pharmaceuticals LP | 7 | $244 |
| Amgen Inc. | 8 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $224 |
| Novo Nordisk Inc | 5 | $184 |
| Cumberland Pharmaceuticals, Inc. | 7 | $164 |
| Inspire Medical Systems, Inc. | 1 | $143 |
| ABBVIE INC. | 3 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Lilly USA, LLC | 2 | $41 |
Products named: JARDIANCE, AIRSUPRA, KRISTALOSE, Ozempic, INSPIRE, Repatha, TRELEGY ELLIPTA, AREXVY.
Industry payments across MD — which companies pay providers there.
